Plasma clearance of neostigmine and pyridostigmine in the dog
- PMID: 667495
- PMCID: PMC1668085
- DOI: 10.1111/j.1476-5381.1978.tb07805.x
Plasma clearance of neostigmine and pyridostigmine in the dog
Abstract
1 The pharmacokinetics of neostigmine and pyridostigmine was studied in conscious dogs by the use of a cross-over design. 2 Both neostigmine and pyridostigmine were cleared from plasma in a biexponential manner. 3 The apparent volume of distribution of pyridostigmine was invariably greater than that of neostigmine, and its fast disposition half-life was approximately three times longer. 4 The whole body clearance and the urinary elimination of pyridostigmine was approximately twice that of neostigmine. 5 The slow disposition half-life of pyridostigmine was approximately three times longer than that of neostigmine, suggesting that the longer duration of action of pyridostigmine is related to the differential clearance of the two quarternary amines from plasma.
Similar articles
-
Plasma clearance of neostigmine and pyridostigmine in rats with ligated renal pedicles.Eur J Pharmacol. 1973 Nov;24(2):252-5. doi: 10.1016/0014-2999(73)90079-4. Eur J Pharmacol. 1973. PMID: 4765748 No abstract available.
-
The simultaneous monitoring of plasma levels of neostigmine and pyridostigmine in man.Methods Find Exp Clin Pharmacol. 1980 Apr;2(2):77-82. Methods Find Exp Clin Pharmacol. 1980. PMID: 7339332
-
A quantitative gas-liquid chromatographic method for the determination of neostigmine and pyridostigmine in human plasma.J Chromatogr. 1976 May 26;120(2):349-58. doi: 10.1016/s0021-9673(76)80012-x. J Chromatogr. 1976. PMID: 1270556
-
Metabolites of neostigmine and pyridostigmine do not contribute to antagonism of neuromuscular blockade in the dog.Anesthesiology. 1984 Nov;61(5):534-9. doi: 10.1097/00000542-198411000-00010. Anesthesiology. 1984. PMID: 6149707
-
Clinical pharmacokinetics of cholinesterase inhibitors.Clin Pharmacokinet. 1986 May-Jun;11(3):236-49. doi: 10.2165/00003088-198611030-00005. Clin Pharmacokinet. 1986. PMID: 3524957 Review.
Cited by
-
Pharmacokinetics and pharmacological effects of neostigmine in man.Br J Clin Pharmacol. 1979 Feb;7(2):149-55. doi: 10.1111/j.1365-2125.1979.tb00915.x. Br J Clin Pharmacol. 1979. PMID: 216382 Free PMC article.
-
Effects of neostigmine and pyridostigmine on serum cholinesterase activity.Can Anaesth Soc J. 1982 May;29(3):287. doi: 10.1007/BF03007140. Can Anaesth Soc J. 1982. PMID: 7074413 No abstract available.
-
Effects of neostigmine and pyridostigmine on serum cholinesterase activity.Can Anaesth Soc J. 1982 Jan;29(1):55-8. doi: 10.1007/BF03007949. Can Anaesth Soc J. 1982. PMID: 7055744
-
Acquired Myasthenia Gravis in a Juvenile Australian Shepherd Dog and Efficacy of Leflunomide Treatment.Case Rep Vet Med. 2025 Aug 13;2025:1607891. doi: 10.1155/crve/1607891. eCollection 2025. Case Rep Vet Med. 2025. PMID: 40843319 Free PMC article.
-
Kinetics of intravenous pyridostigmine in man.Br J Clin Pharmacol. 1981 Apr;11(4):406-8. doi: 10.1111/j.1365-2125.1981.tb01146.x. Br J Clin Pharmacol. 1981. PMID: 7259938 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources